Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant gap (Expand Search)
Showing 1,161 - 1,180 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant genes) OR (significant changes)) decrease ))', query time: 0.65s Refine Results
  1. 1161
    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.

    Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1162
    miR-1247-3p plasmid.

    miR-1247-3p plasmid. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 1163
    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>.

    Molecular docking showed that ABT-199 can fit into active site of ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1164
    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures.

    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1165
    Dual luciferase primer.

    Dual luciferase primer. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 1166
    shCCND1 plasmid.

    shCCND1 plasmid. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 1167
    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>.

    Amino acids interactions and binding energy describe that ABT-199 binds to ALK<sup>Mutant</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1168
    Western blot analysis of drug combinations.

    Western blot analysis of drug combinations. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1169
    ALKL1196M –ABT199 interactions.

    ALKL1196M –ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1170
    Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells.

    Overexpression of miR-1247-3p promoted apoptosis and inhibited resistance in drug-resistant cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 1171
    ALK<sup>wt</sup>–ABT199 interactions.

    ALK<sup>wt</sup>–ABT199 interactions. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1172
    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression.

    BCL2 protein keeps their expression in different conditions treatment nevertheless each EML4-ALK cell modells exhibit variable expression. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1173
    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side.

    ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1174
    Effect of miR-1247-3p on survival in colorectal cancer patients.

    Effect of miR-1247-3p on survival in colorectal cancer patients. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1175
    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>.

    BCL2 antiapoptotic protein exhibits heterogeneous expression in Ba/F3 EML4-ALK<sup>mutants</sup>. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1176
    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment.

    Loewe synergy-antagonism score analysis shows additive and synergistic effects after ALKi and ABT-199 combination treatment. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1177
    S1 Raw images -

    S1 Raw images - by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1178
    Introduction to the dataset.

    Introduction to the dataset. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1179
    Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells.

    Downregulation of miR-1247-3p inhibited apoptosis and reduced chemosensitivity in cells. by Dequan Wang (6007007)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 1180
    Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein.

    Negative (Prednisone) and basal (ATP) control compounds binding to ALK protein. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: